NASDAQ:FHTX
Foghorn Therapeutics Inc.
- Stock
Last Close
5.81
17/05 20:00
Market Cap
128.76M
Beta: 2.16
Volume Today
59.69K
Avg: 76.72K
PE Ratio
−1.07
PFCF: −0.97
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | 0.00 50.84% | 0.05 1,771.43% | 0.12 151.54% | |||
cash conversion cycle | -102.77K - | -263.81 99.74% | |||||
cash per share | 2.04 - | 0.68 66.79% | 16.82 2,383.87% | 4.15 75.32% | 15.37 270.36% | 5.58 63.73% | |
company equity multiplier | -1.10 - | -0.25 76.85% | 1.75 788.78% | 5.37 206.89% | 3.62K 67,273.75% | -3.70 100.10% | |
days of inventory outstanding | |||||||
days of payables outstanding | 102.77K - | 263.81 99.74% | |||||
days of sales outstanding | 83.02K - | ||||||
dividend yield | |||||||
ebit per revenue | -159.37 - | -76.37 52.08% | -6.09 92.02% | -3.16 48.14% | |||
ebt per ebit | 1.01 - | 1.00 1.01% | 1.00 0.31% | 1.01 0.19% | 0.93 7.58% | 0.87 6.08% | |
effective tax rate | -0.00 - | -0.01 235.14% | -0.01 34.73% | -0.02 32.20% | 0.00 100.40% | -0.04 59,272.18% | |
enterprise value multiple | -12.63 - | -8.07 36.10% | -3.22 60.10% | -8.50 164.10% | 0.25 102.91% | -2.37 1,060.42% | |
fixed asset turnover | 0.01 - | 0.02 240.95% | 0.39 1,554.97% | 0.80 104.48% | |||
free cash flow per share | -1.23 - | -2.14 73.48% | -4.30 101.01% | -1.44 66.47% | 4.63 421.03% | -2.84 161.46% | |
gross profit margin | 1 - | 1 0% | 1.00 0.10% | 0.75 25.28% | |||
interest coverage | -70.21 - | -94.60 34.73% | -70.00 26.00% | -52.85 24.50% | 10.13 119.16% | ||
inventory turnover | |||||||
long term debt to capitalization | -0.22 - | -0.14 33.68% | 0.35 340.70% | 0.35 0.45% | 1.00 187.98% | -0.90 190.18% | |
net income per ebt | 1 - | 1.01 1.06% | 1.01 0.36% | 1.02 0.45% | 1.00 1.85% | 1.04 4.49% | |
net profit margin | -162.28 - | -78.26 51.77% | -5.66 92.76% | -2.88 49.11% | |||
operating cash flow per share | -1.15 - | -2.09 81.49% | -2.83 35.25% | -1.35 52.27% | 4.66 444.35% | -2.81 160.44% | |
operating cycle | |||||||
operating profit margin | -159.37 - | -76.37 52.08% | -6.09 92.02% | -3.16 48.14% | |||
payables turnover | 0.00 - | 1.38 38,856.31% | |||||
pretax profit margin | -160 - | -76.82 51.99% | -5.66 92.63% | -2.76 51.29% | |||
price fair value | -9.06 - | -4.56 49.70% | 1.53 133.62% | 8.78 472.92% | 2.37K 26,897.79% | -3.51 100.15% | |
receivables turnover | 0.00 - | ||||||
return on assets | -0.61 - | -2.31 278.08% | -0.27 88.19% | -0.20 27.26% | -0.27 35.40% | -0.34 28.02% | |
return on capital employed | -0.66 - | -5.27 701.41% | -0.29 94.51% | -0.21 26.13% | -1.72 704.83% | -0.47 72.44% | |
return on equity | 0.67 - | 0.59 12.46% | -0.48 181.31% | -1.07 123.24% | -972.09 91,124.15% | 1.28 100.13% | |
total debt to capitalization | -0.22 - | -0.23 6.86% | 0.36 254.26% | 0.38 4.59% | 1.00 165.49% | -1.40 240.65% |
All numbers in USD (except ratios and percentages)